This website uses cookies to ensure you get the best experience on our website.
Read through the Privacy Policy to understand better
18.13 (0%)
As of Feb 14, 2025
Source: Annual Report to the SEC filed on Feb 26, 2025
Axogen, Inc. is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair.